Search filters

List of works by Zhi-Cheng Jing

A global view of pulmonary hypertension.

scientific article published on 11 March 2016

Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications : Bamberg, Germany. 23-25 June, 2017

article

Antiphospholipid Syndrome in Chronic Thromboembolic Pulmonary Hypertension: A Well-Defined Subgroup of Patients

scientific article published on 21 June 2019

BMPR2 Mutations Influence Phenotype More Obviously in Male Patients With Pulmonary Arterial Hypertension

scientific article published on August 25, 2012

BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

scientific article

Clinical features of paediatric pulmonary hypertension: a registry study

scientific article published on January 11, 2012

Comparison of hemodynamic parameters in treatment-naïve and pre-treated patients with pulmonary arterial hypertension in the randomized phase III PATENT-1 study.

scientific article published on 24 December 2016

DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension

scientific article published on 09 December 2020

Effect of ambrisentan on echocardiographic and Doppler measures from patients in China with pulmonary arterial hypertension

scientific article published on 17 August 2020

How should a physician approach the pharmacological management of chronic thromboembolic pulmonary hypertension?

scientific article published on 05 October 2020

Inhibition of CRTH2-mediated Th2 activation attenuates pulmonary hypertension in mice

scientific article published on 03 July 2018

Lower Socioeconomic Status Is Associated with Worse Outcomes in Pulmonary Arterial Hypertension

scientific article published on December 6, 2012

Macitentan and morbidity and mortality in pulmonary arterial hypertension

scientific article

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

scientific article published on 8 September 2017

MicroRNA-483 amelioration of experimental pulmonary hypertension

scientific article published on 23 April 2020

Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients

scientific article published on July 7, 2011

Oestradiol ameliorates monocrotaline pulmonary hypertensionviaNO, prostacyclin and endothelin-1 pathways

scientific article published on August 30, 2012

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study)

scientific article published on September 1, 2013

Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study

scientific article published on September 21, 2011

Prevalence, Genetic Background, and Clinical Phenotype of Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension

scientific article published in 2022

Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension

scientific article published on 04 May 2012

Spermine Promotes Pulmonary Vascular Remodelling and Its Synthase is a Therapeutic Target for Pulmonary Arterial Hypertension

scientific article published on 08 June 2020

The effects of atorvastatin on pulmonary arterial hypertension and expression of p38, p27, and Jab1 in rats

scientific article published on October 1, 2010

The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension

scientific article published on May 6, 2013

Usefulness of Intravenous Adenosine in Idiopathic Pulmonary Arterial Hypertension as a Screening Agent for Identifying Long-Term Responders to Calcium Channel Blockers

scientific article published on March 28, 2012